Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -6665.02x is 60424% below its 5-year average of -11.01x, near the low end of its 5-year range (-6665.02x–-1.65x).
As of the fiscal period ended Tuesday, December 31, 2024. 397.49% below its 12-month average of -1339.74x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2024 (2024-12-31): -6665.02x.
INTEREST COVERAGE RATIO
-6665.02x
INTEREST COVERAGE RATIO AVG TTM
-1339.74x
INTEREST COVERAGE RATIO AVG 3Y
-197.45x
INTEREST COVERAGE RATIO AVG 5Y
-11.01x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-397.49%
CURRENT VS 3Y AVG
-3275.54%
CURRENT VS 5Y AVG
-60423.54%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-2.97x
median of 292 covered companies
CURRENT VS SECTOR MEDIAN
-223934.23%
vs the sector median at left
Aclarion, Inc.
Market Cap
$6.74M
Interest Coverage Ratio
-6665.02x
TTM Avg
-1339.74x
3Y Avg
-197.45x
5Y Avg
-11.01x
Market Cap
$6.76M
Interest Coverage Ratio
-82777.81x
TTM Avg
11.97x
3Y Avg
11.97x
5Y Avg
11.97x
Market Cap
$6.72M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.88M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.03M
Interest Coverage Ratio
-496.55x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.44M
Interest Coverage Ratio
-545.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.34M
Interest Coverage Ratio
N/A
TTM Avg
1010.31x
3Y Avg
1010.31x
5Y Avg
509.98x
Market Cap
$6.10M
Interest Coverage Ratio
-438.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aclarion, Inc. (ACON) | $6.74M | -6665.02x | -1339.74x | -197.45x | -11.01x |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | -82777.81x | 11.97x | 11.97x | 11.97x |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | N/A | N/A | N/A | N/A |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | N/A | N/A | N/A | N/A |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.03M | -496.55x | N/A | N/A | N/A |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | -545.69x | N/A | N/A | N/A |
| Biomerica, Inc. (BMRA)vs › | $6.34M | N/A | 1010.31x | 1010.31x | 509.98x |
| Femasys Inc. (FEMY)vs › | $6.10M | -9.30x | N/A | N/A | N/A |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | -438.08x | N/A | N/A | N/A |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | -1153.85x | N/A | N/A | N/A |
Interest Coverage
-6665.0x
Debt/Equity
0.00
Current Ratio
16.20
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2024-12-31 | -6665.02x |
| 2024-09-30 | -18.12x |
| 2024-06-30 | -8.88x |
| 2024-03-31 | -3.80x |
| 2023-12-31 | -2.86x |
| 2023-09-30 | -6.99x |
| 2023-06-30 | -29.83x |
| 2023-03-31 | -855.99x |
| 2022-12-31 | -641.25x |
| 2022-09-30 | -789.01x |
| 2022-06-30 | -1.65x |
| 2022-03-31 | -4.75x |
| 2021-12-31 | -6.27x |
| 2021-09-30 | -4.76x |
| 2021-06-30 | -7.57x |
| 2021-03-31 | -8.05x |
| 2020-12-31 | -8.50x |
| 2020-09-30 | -51.68x |
| 2020-06-30 | -6.25x |
| 2020-03-31 | -6.25x |
